Top Biopharmaceuticals Third Party Logistics 3pl Companies

Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Biopharmaceuticals Third Party Logistics 3pl Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Biopharmaceuticals Third Party Logistics 3pl industry players.

Biopharmaceuticals Third Party Logistics 3pl Market Competitive Landscape

The market is highly fragmented, with a large number of players. This fragmentation makes it difficult for major players to enter a few countries around the world. As a result, the big players are consolidating, which will allow them to accept modern technologies from small or regional players and expand their global presence.

Top Players in Biopharmaceuticals Third Party Logistics 3pl Market

  • DHL (Germany) 
  • FedEx (USA) 
  • United Parcel Service (UPS) (USA) 
  • Kuehne+Nagel (Switzerland) 
  • DB Schenker (Germany) 
  • Agility (Kuwait) 
  • AmerisourceBergen Corporation (USA) 
  • McKesson Corporation (USA) 
  • Cardinal Health (USA) 
  • Thermo Fisher Scientific (USA) 
  • Cencora, Inc. (USA) 
  • EVERSANA (USA) 
  • Kerry Logistics Network Limited (Hong Kong) 
  • SF Express (China) 
  • XPO Logistics (USA) 
  • CEVA Logistics (Switzerland) 
  • Almac Group (UK) 
  • Cryoport, Inc. (USA)

Biopharmaceuticals Third Party Logistics 3pl Market

REPORT OVERVIEW BUY NOW

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Biopharmaceuticals Third Party Logistics 3pl Market size was valued at USD 124.8 billion in 2023 and is poised to grow from USD 132.41 billion in 2024 to USD 212.64 billion by 2032, growing at a CAGR of 6.1% during the forecast period (2025-2032). 

The market is highly fragmented, with a large number of players. This fragmentation makes it difficult for major players to enter a few countries around the world. As a result, the big players are consolidating, which will allow them to accept modern technologies from small or regional players and expand their global presence. 'DHL (Germany) ', 'FedEx (USA) ', 'United Parcel Service (UPS) (USA) ', 'Kuehne+Nagel (Switzerland) ', 'DB Schenker (Germany) ', 'Agility (Kuwait) ', 'AmerisourceBergen Corporation (USA) ', 'McKesson Corporation (USA) ', 'Cardinal Health (USA) ', 'Thermo Fisher Scientific (USA) ', 'Cencora, Inc. (USA) ', 'EVERSANA (USA) ', 'Kerry Logistics Network Limited (Hong Kong) ', 'SF Express (China) ', 'XPO Logistics (USA) ', 'CEVA Logistics (Switzerland) ', 'Almac Group (UK) ', 'Cryoport, Inc. (USA)'

The growing demand for efficient logistics solutions that can safely transport temperature-sensitive medications is expected to drive the growth of the biopharmaceutical third-party logistics (3PL) market. The introduction of a wide range of biologics and biosimilars, all of which require temperature-controlled logistics service to be distributed, is expected to be the driving force behind the growth of the biopharmaceutical third-party logistics market. The increased adoption of automation in manufacturing facilities in an effort to reduce operational costs is driving demand for third-party logistics services. Furthermore, the rising prevalence of chronic diseases is driving up demand for biologics, which is fuelling the growth of the biopharmaceutical third-party logistics (3PL) market.

Companies are investing more money in R&D to develop efficient value-added services in order to meet the growing demand for advanced logistic services in the biopharmaceutical industry. Smart sensor technology refers to the technology that measures the ambient conditions inside the vehicle. DHL is able to improve its distribution network in part because of the implementation of technologically advanced devices.

North America's market was the most profitable and held the largest share in 2021, accounting for more than 42.0% of total revenue generated worldwide. This is primarily due to the region's dominance in the biologics and pharmaceutical medication markets, as well as an increase in the number of biopharmaceuticals shipped out of and brought into the region. Furthermore, due to the high cost of medical treatment, the region has a relatively high rate of adoption of various cutting-edge technologies.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Third Party Logistics Market
Buy Now GET FREE SAMPLE
Pharmaceutical Logistics Market
Buy Now GET FREE SAMPLE
Healthcare Logistics Market
Buy Now GET FREE SAMPLE
Biopharmaceuticals Contract Manufacturing Market
Buy Now GET FREE SAMPLE
Logistics Market
Buy Now GET FREE SAMPLE
E-Commerce Logistics Market
Buy Now GET FREE SAMPLE
Connected Logistics Market
Buy Now GET FREE SAMPLE
Cold Chain Logistics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Biopharmaceuticals Third Party Logistics 3pl Market
Biopharmaceuticals Third Party Logistics 3pl Market

Report ID: SQMIG35C2014

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE